|Articles|March 5, 2018
Jamie Macdonald Appointed as the New CEO of PAREXEL
Advertisement
PAREXEL International Corporation announced the appointment of Jamie Macdonald as CEO effective March 15, 2018. The current CEO and co-founder of the company, Josef von Rickenbach will retire from his daily duties and continue as Chairman of the Board.
Read the full release
here
.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
NIMBLE Trial Reveals New Insights on Complement Inhibition in gMGSeptember 15th 2025
Q&A: Strategies for Successful Global Clinical Trial DeliverySeptember 12th 2025
Vabysmo Shows Long-Term Efficacy and Safety in Wet AMD, PCV PatientsSeptember 12th 2025
Latest NIMBLE Study Results Highlight Progress in gMG ResearchSeptember 12th 2025
Advertisement
Advertisement
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
